BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23536922)

  • 1. Systemic mastocytosis.
    Bouvier S; Arnaud A
    Blood; 2013 Feb; 121(7):1071. PubMed ID: 23536922
    [No Abstract]   [Full Text] [Related]  

  • 2. Indolent systemic mastocytosis.
    Vano-Galvan S; De la Hoz B; Nuñez R; Jaen P
    Isr Med Assoc J; 2010 Mar; 12(3):185-7. PubMed ID: 20684189
    [No Abstract]   [Full Text] [Related]  

  • 3. Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.
    Golardi N; Sramek JE; Myers JB; Saffer H; George TI; Czuchlewski DR
    Hum Pathol; 2014 Feb; 45(2):417-20. PubMed ID: 24182560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.
    Zanotti R; Bonadonna P; Bonifacio M; Artuso A; Schena D; Rossini M; Perbellini O; Colarossi S; Chilosi M; Pizzolo G
    Haematologica; 2011 Mar; 96(3):482-4. PubMed ID: 21193416
    [No Abstract]   [Full Text] [Related]  

  • 5. Anemia, leukocytosis, abdominal pain, flushing, and bone and skin lesions.
    Álvarez-Twose I; Vañó-Galván S; Sanchez-Muñoz L; Fernandez-Zapardiel S; Escribano L
    Cleve Clin J Med; 2012 Jun; 79(6):384-6. PubMed ID: 22660869
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive systemic mastocytosis with Charcot-Leyden crystals-associated crystal storing histiocytosis in bone marrow.
    Alayed KM; Alabdulaali MK; Alkhairy KS; Elnour S; Alhajjaj A
    Pathology; 2010 Jan; 42(1):85-7. PubMed ID: 20025488
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic mastocytosis associated with acute myeloid leukaemia.
    Fong C; Tong M
    Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
    [No Abstract]   [Full Text] [Related]  

  • 8. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thumbprints in the ileum.
    Mecklenburg I; Probst A; Messmann H
    Gastroenterology; 2011 May; 140(5):1400, 1698. PubMed ID: 21440584
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mastocytosis simulating osseous metastatic disease.
    Metzgeroth G; Dinter D; Erben P; La Rosée P; Hehlmann R; Hastka J
    Br J Haematol; 2007 Jan; 136(1):1. PubMed ID: 17222193
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies in Allergy: Is a Bone Marrow Biopsy Optional or Essential in the Evaluation of the Patient with a Suspected Mast Cell Disorder?
    Greenberger PA; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1134-1138. PubMed ID: 30630762
    [No Abstract]   [Full Text] [Related]  

  • 14. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flushing out the diagnosis.
    Geoghegan P; Moran P; Sexton DJ; O'Reilly MW; O'Dwyer M; O'Regan A
    QJM; 2013 Dec; 106(12):1121-2. PubMed ID: 23824941
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive systemic mastocytosis.
    Inaoui R; Petit B; Jaccard A; Bertin P; Trèves R
    Joint Bone Spine; 2003 Feb; 70(1):64-6. PubMed ID: 12639621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
    Ustun C; Savage NM; Gotlib J; Bhalla K; Manaloor E; George TI
    Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal manifestations of systemic mastocytosis.
    Lee JK; Whittaker SJ; Enns RA; Zetler P
    World J Gastroenterol; 2008 Dec; 14(45):7005-8. PubMed ID: 19058339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mastocytosis in childhood].
    Renke J; Lange M
    Przegl Lek; 2006; 63(7):551-3. PubMed ID: 17203807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis.
    Elliott MA; Pardanani A; Li CY; Tefferi A
    Leukemia; 2004 May; 18(5):1027-9. PubMed ID: 15014525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.